DE602005006157D1 - STABILISIERTE 99mTC ZUSAMMENSETZUNG - Google Patents

STABILISIERTE 99mTC ZUSAMMENSETZUNG

Info

Publication number
DE602005006157D1
DE602005006157D1 DE602005006157T DE602005006157T DE602005006157D1 DE 602005006157 D1 DE602005006157 D1 DE 602005006157D1 DE 602005006157 T DE602005006157 T DE 602005006157T DE 602005006157 T DE602005006157 T DE 602005006157T DE 602005006157 D1 DE602005006157 D1 DE 602005006157D1
Authority
DE
Germany
Prior art keywords
99mtc
tetrofosmin
stabilized
composition
lyophilised
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005006157T
Other languages
English (en)
Other versions
DE602005006157T2 (de
Inventor
Grethe Karin Martinussen
Gry Stensrud
Ole Kristian Hjelstuen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare Ltd
Original Assignee
GE Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GE Healthcare Ltd filed Critical GE Healthcare Ltd
Publication of DE602005006157D1 publication Critical patent/DE602005006157D1/de
Application granted granted Critical
Publication of DE602005006157T2 publication Critical patent/DE602005006157T2/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Lock And Its Accessories (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Devices For Supply Of Signal Current (AREA)
  • Noodles (AREA)
  • Train Traffic Observation, Control, And Security (AREA)
DE602005006157T 2004-12-15 2005-10-14 STABILISIERTE 99mTC ZUSAMMENSETZUNG Active DE602005006157T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0427392 2004-12-15
GBGB0427392.6A GB0427392D0 (en) 2004-12-15 2004-12-15 Stabilised 99mTc compositions
PCT/GB2005/003975 WO2006064175A1 (en) 2004-12-15 2005-10-14 STABILISED 99mTC COMPOSITIONS

Publications (2)

Publication Number Publication Date
DE602005006157D1 true DE602005006157D1 (de) 2008-05-29
DE602005006157T2 DE602005006157T2 (de) 2009-05-28

Family

ID=34090037

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005006157T Active DE602005006157T2 (de) 2004-12-15 2005-10-14 STABILISIERTE 99mTC ZUSAMMENSETZUNG

Country Status (17)

Country Link
US (1) US9694092B2 (de)
EP (1) EP1824525B1 (de)
JP (1) JP5064236B2 (de)
KR (1) KR101297523B1 (de)
CN (2) CN101107017A (de)
AT (1) ATE392218T1 (de)
AU (1) AU2005315503B2 (de)
BR (1) BRPI0518636B8 (de)
CA (1) CA2590620C (de)
DE (1) DE602005006157T2 (de)
ES (1) ES2306219T3 (de)
GB (1) GB0427392D0 (de)
MX (1) MX2007007223A (de)
NO (1) NO340538B1 (de)
PL (1) PL1824525T3 (de)
RU (1) RU2403067C2 (de)
WO (1) WO2006064175A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2029178B1 (de) * 2006-06-21 2012-03-14 GE Healthcare Limited Radiopharmazeutische produkte
US20100056826A1 (en) * 2006-11-09 2010-03-04 Nihon Medi-Physicis Co., Ltd. Radioactive diagnostic imaging agent
GB0718386D0 (en) * 2007-09-21 2007-10-31 Ge Healthcare As Improved radiopharmaceutical formulation
RU2463075C1 (ru) * 2011-07-01 2012-10-10 Российская Федерация, От Имени Которой Выступает Министерство Образования И Науки Российской Федерации СПОСОБ ПОЛУЧЕНИЯ МЕЧЕННОГО ТЕХНЕЦИЕМ-99m НАНОКОЛЛОИДА
RU2512595C1 (ru) * 2013-01-09 2014-04-10 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт онкологии" Сибирского отделения Российской академии медицинских наук (ФГБУ "НИИ онкологии" СО РАМН) СПОСОБ ПОЛУЧЕНИЯ РЕАГЕНТА ДЛЯ ПРИГОТОВЛЕНИЯ МЕЧЕННОГО ТЕХНЕЦИЕМ 99-m НАНОКОЛЛОИДА НА ОСНОВЕ ГАММА-ОКСИДА АЛЮМИНИЯ
RU2543654C1 (ru) * 2013-11-29 2015-03-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Национальный исследовательский Томский политехнический университет" СПОСОБ ПОЛУЧЕНИЯ МЕЧЕННОГО ТЕХНЕЦИЕМ-99m НАНОКОЛЛОИДА
EP2899195A1 (de) 2014-01-28 2015-07-29 ROTOP Pharmaka AG Stabilisierte Form von Tetrofosmin und seine Verwendung
EP3183009B1 (de) * 2015-09-30 2023-08-09 Duke University Kontrastmittel zur magnetresonanzabbildung
IT201600101875A1 (it) * 2016-10-11 2018-04-11 Advanced Accelerator Applications Int S A Composizioni liofilizzate comprendenti rhAnnexin V-128, processo per la loro preparazione e loro uso per la preparazione di formulazioni contenenti 99mTc-rhAnnexin V-128
AU2017314293B2 (en) * 2017-03-08 2022-03-03 Jubilant Generics Limited (Formerly A Division Of Jubilant Life Sciences Limited) An improved process for the preparation of tetrofosmin or acid addition salt thereof
US11857647B2 (en) * 2017-11-23 2024-01-02 Jubilant Draximage, Inc. Pharmaceutical composition comprising tetrofosmin and pharmaceutically acceptable salts thereof
JP2022503281A (ja) * 2018-10-06 2022-01-12 ジュビラント ジェネリックス リミテッド 硫黄コロイドの医薬組成物及びその方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA761944B (en) 1975-04-30 1977-03-30 Procter & Gamble Stable radiographic scanning agents
JPS5750928A (en) 1980-09-13 1982-03-25 Nippon Mejifuijitsukusu Kk Diagnostic agent for scanning bone
JPS5896031A (ja) * 1981-12-03 1983-06-07 Nippon Mejifuijitsukusu Kk 放射性診断剤およびその製造用組成物
GB8808414D0 (en) 1988-04-11 1988-05-11 Amersham Int Plc Ligands & cationic complexes thereof with technetium-99m
JP2860157B2 (ja) 1990-10-31 1999-02-24 日本メジフィジックス株式会社 腎機能測定用の既放射能標識テクネチウムキレート注射剤の製造方法
US5300280A (en) * 1992-02-14 1994-04-05 Mallinckrodt Medical, Inc. Stabilized radiopharmaceutical kits
DE60036382D1 (de) 1999-06-21 2007-10-25 Nihon Mediphysics Co Ltd Verfahren zur verabreichung von arzneimitteln mit bindungsaffinität zum plasmaprotein und verwendung der zusammensetzung in dem verfahren
CN1184225C (zh) * 2000-06-28 2005-01-12 北京师范大学 一种替曲膦季鏻盐及其制法和二步法替曲膦药盒及其应用
GB0031592D0 (en) 2000-12-28 2001-02-07 Nycomed Amersham Plc Stabilised radiopharmaceutical compositions
US6713042B2 (en) * 2001-02-26 2004-03-30 Bristol-Myers Squibb Pharma Company Ascorbic acid analogs for metalloradiopharmaceuticals

Also Published As

Publication number Publication date
NO20073158L (no) 2007-07-04
MX2007007223A (es) 2007-08-14
BRPI0518636B8 (pt) 2021-07-27
PL1824525T3 (pl) 2008-11-28
ES2306219T3 (es) 2008-11-01
JP2008524178A (ja) 2008-07-10
CA2590620A1 (en) 2006-06-22
AU2005315503A1 (en) 2006-06-22
KR101297523B1 (ko) 2013-08-16
DE602005006157T2 (de) 2009-05-28
GB0427392D0 (en) 2005-01-19
ATE392218T1 (de) 2008-05-15
WO2006064175A1 (en) 2006-06-22
RU2403067C2 (ru) 2010-11-10
US9694092B2 (en) 2017-07-04
BRPI0518636A2 (pt) 2008-12-02
KR20070089156A (ko) 2007-08-30
US20090311178A1 (en) 2009-12-17
EP1824525A1 (de) 2007-08-29
BRPI0518636B1 (pt) 2016-12-13
AU2005315503B2 (en) 2011-06-02
CA2590620C (en) 2012-12-04
CN101107017A (zh) 2008-01-16
JP5064236B2 (ja) 2012-10-31
CN103028123A (zh) 2013-04-10
EP1824525B1 (de) 2008-04-16
NO340538B1 (no) 2017-05-02
US20110008252A9 (en) 2011-01-13
RU2007120467A (ru) 2009-01-27

Similar Documents

Publication Publication Date Title
ATE392218T1 (de) Stabilisierte 99mtc zusammensetzung
BRPI0508579A (pt) composto, composição farmacêutica, e, uso de um composto
TNSN07341A1 (en) Pharmaceutical composition comprising an omega-carboxyaryl substituted diphenyl urea for the treatment of cancer
TW200800967A (en) Benzimidazole thiophene compounds
CL2009000906A1 (es) Compuestos derivados de 4-imidazolil y 4-triazolil de 2-(6-(4-cicloalquilpiperazin-1-il)pirimidin-4-il)-1h-pirazol-3(2h)ona inhibidores de hif-prolil-4-hidroxilasas; procedimiento de preparacion; composicion farmaceutica; y uso del compuesto en el tratamiento de enfermedades cardiovasculares, renales y hematologicas.
DE602006020295D1 (de) Azabenzimidalzolderivate, ihre herstellung und ihre verwendung als antikrebsmittel
NO20074737L (no) Isokinolinforbindelser og fremgangsmater for anvendelse derav
TW200640857A (en) Substituted pyrroles and imidazoles, compositions containing same, manufacturing process therefor and use thereof
MX2009011493A (es) Complejo de excipiente farmaceutico.
WO2012168885A3 (en) Bisacodyl and its analogues as drugs for use in the treatment of cancer
WO2006088903A3 (en) Pyrazole compounds
TW200718698A (en) Process for preparing new tiotropium salts, new tiotropium salts as such and pharmaceutical compositions thereof
UA87312C2 (ru) КОМПОЗИЦИЯ ДЛЯ АЭРОЗОЛЬНОЙ ИНГАЛЯЦИИ β-АГОНИСТОВ
WO2007087026A3 (en) Solid-state form of amg 706 and pharmaceutical compositions thereof
MX2009000768A (es) Lactamas macrociclicas.
WO2009013358A3 (en) Polysaccharides grafted by polyamines for the preparation of radiopharmaceutical compositions
HRP20080422T3 (en) Satraplatin for treating resistant or refractory tumors
TW200800993A (en) Organic compounds
MX2008001412A (es) Derivados de fenilpiridina, su obtencion y su utilizacion como agentes farmaceuticos.
UA92180C2 (en) Benzimidazole thiophene compounds as plk inhibitors
NO20085285L (no) 2-alkosy-3,4,5-tnhydroksyalkylamidbenzazepiner, deres fremstilling og bruk samt preparater inneholdende disse
EA200870566A1 (ru) 2-алкокси-3,4,5-тригидроксиалкиламидобензотиазепины, их получение, композиции, содержащие их, и применение
WO2018222169A3 (en) VANADIUM INSULIN MIMETICS, PREPARATION METHODS AND METHODS FOR TREATING DIABETES
GB0327186D0 (en) Organic compounds
TH116664B (th) สารประกอบเชิงซ้อนเหล็ก-คาร์โบไฮเดรต

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: HAMMONDS LLP, LONDON, GB

R082 Change of representative

Ref document number: 1824525

Country of ref document: EP

Representative=s name: J D REYNOLDS & CO., GB